Who makes Cetirizine 40 mg?

Cetirizine 40 mg is developed by University of Phayao.

What development phase is Cetirizine 40 mg in?

Cetirizine 40 mg is in Phase 1.

Last reviewed 2026-04-20 · How we verify

Cetirizine 40 mg

University of Phayao · Phase 1 active Small molecule Quality 0/100

At a glance

Generic name	Cetirizine 40 mg
Sponsor	University of Phayao
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Comparing Standard-Dose and High-Dose Cetirizine for Acute Urticaria (NA)
Long-Term Extension Study of Ofatumumab in Subjects With Pemphigus Vulgaris (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Cetirizine 40 mg CI brief — competitive landscape report
Cetirizine 40 mg updates RSS · CI watch RSS
University of Phayao portfolio CI